UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058636
Receipt number R000067054
Scientific Title A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"
Date of disclosure of the study information 2025/07/29
Last modified on 2025/07/29 16:55:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"

Acronym

A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"

Scientific Title

A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"

Scientific Title:Acronym

A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"

Region

Japan


Condition

Condition

Attention Deficit/Hyperactivity Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The applicant newly defines a group of individuals who did not exhibit ADHD symptoms during childhood but first became aware of such symptoms in adulthood as Pseudo-ADHD and is currently investigating their clinical psychological characteristics. In the present study, an exploratory examination will be conducted to assess how factors such as fear of COVID-19, current interpersonal stress events, coping strategies, social functioning, and occupational stress influence the manifestation of Pseudo-ADHD. These data will serve as theoretical support for the effectiveness of interpersonal counseling in addressing depressive states following the resolution of the COVID-19 pandemic.

Basic objectives2

Others

Basic objectives -Others

Comparisons will be made among scores on various assessment scales, including fear of COVID-19 and depression, as well as analyses of their associations while considering participants' background information.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

This study examines the influence of scores on various assessment scales on the presence or absence of "Pseudo-ADHD", including the Interpersonal Stress Event Scale, the Brief COPE, the Work and Social Adjustment Scale (WSAS), the Hospital Anxiety and Depression Scale (HADS), the Brief Job Stress Questionnaire, and the Japanese version of the Fear of COVID-19 Scale (FCV-19S-J).

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Individuals who are able to provide informed consent to participate in a survey conducted via a crowdsourcing service (Lancers: https://www.lancers.jp/help/terms).

Key exclusion criteria

None

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Hisae
Middle name
Last name Ono

Organization

Kwansei Gakuin University

Division name

Department of Integrated Psychological Sciences, School of Humanities

Zip code

662-8501

Address

1-155 Uegahara Ichibancho, Nishinomiya, Hyogo

TEL

0798-54-4517

Email

hisaono@kwansei.ac.jp


Public contact

Name of contact person

1st name Hisae
Middle name
Last name Ono

Organization

Kwansei Gakuin University

Division name

Department of Integrated Psychological Sciences, School of Humanities

Zip code

662-8501

Address

1-155 Uegahara Ichibancho, Nishinomiya, Hyogo

TEL

0798-54-4517

Homepage URL


Email

hisaono@kwansei.ac.jp


Sponsor or person

Institute

Kwansei Gakuin University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kwansei Gakuin University Institutional Review Board for Medical and Biological Research Involving Human Subiects(KGIRB)

Address

1 Ban Gakuen Uegahara, Sanda-shi, Hyogo

Tel

079-565-9052

Email

med-ethic@kwansei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 06 Month 19 Day

Date of IRB

2025 Year 06 Month 19 Day

Anticipated trial start date

2025 Year 06 Month 19 Day

Last follow-up date

2025 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Online cross-sectional survey study


Management information

Registered date

2025 Year 07 Month 29 Day

Last modified on

2025 Year 07 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067054